DOW JONES NEWSWIRES

Below is a synopsis of major releases from Monday afternoon:

TI Weighed Down By Lower Sales, Margins But CEO Sees 'Healthy Trends'

Texas Instruments Inc.'s (TXN) profit dropped 56% on lower sales and margins, but revenue grew from the first quarter on strong analog chip sales and a seasonal increase in calculator sales. Shares fell 1.1%, to $23.35 in after-hours trading, although the communications-chip giant predicted third-quarter earnings above Wall Street's expectations. Chief Executive Rich Templeton said TI is seeing "healthy trends" in its profitability but "it will likely take some time before the economy strengthens."

Legg Mason Swings To Profit On Prior-Year Support To Funds

Legg Mason Inc. (LM) swung to a profit, with results coming in above analysts' expectations amid a 33% drop in operating costs and prior-year support to money-market funds. Shares of the asset manager jumped 4.9% after-hours to $26.15.

Zions In The Red Amid Sharply Higher Loan-Loss Provisions

Zions Bancorp Inc. (ZION) swung to a loss as provisions for loan losses soared. Shares fell 3.4%, to $11.80 in after-hours trading, though the regional bank's third consecutive loss was narrower than analysts were expecting. Meanwhile, net charge-offs - loans the bank no longer thinks are collectible - soared to $347.5 million from $151.7 million in the first quarter.

ICU Medical Net Jumps On Higher Demand, Boosts Year View

ICU Medical Inc.'s (ICUI) profit grew by 20% as demand for the company's disposable medical products was stable, despite the economic downturn. The company also raised its full-year earnings, revenue and margins targets, due to improvements in its existing businesses as well as its acquisition of Hospira Inc.'s (HSP) critical-care product line. Still, shares were down 3.3%, to $42.52 in after-hours trading.

Lincare Profit Hurt By Medicare Changes, Slumping Margins

Lincare Holdings Inc.'s (LNCR) profit dropped 44%, as operating margins slumped and reductions in Medicare reimbursement continued to hurt results. Chief Executive John Byrnes said that while the Medicare changes had been challenging, the company experienced strong growth in its core respiratory business as competitors struggle to deal with the cuts. Shares rose 0.8%, to $24.25 in after-hours trading, as earnings topped estimates.

Brown & Brown Posts Slightly Higher Net As Demand Holds Steady

Brown & Brown Co.'s (BRO) earnings inched up as the insurance agency and brokerage firm continued to fend off the economic downturn. "This insurance market continues to be challenging due, principally, to the current economic environment," said Chief Executive J. Powell Brown. Shares were inactive in late trading.